Interaction of 1,2,3,4-tetrahydroisoquinoline with some components of cigarette smoke: Potential implications for Parkinson's disease

被引:11
|
作者
SotoOtero, R
Riguera, R
MendezAlvarez, E
SanchezSellero, I
Lamas, MLR
机构
[1] UNIV SANTIAGO DE COMPOSTELA, FAC CHEM, DEPT ORGAN CHEM, SANTIAGO DE COMPOSTELA, SPAIN
[2] UNIV SANTIAGO DE COMPOSTELA, FAC MED, INST LEGAL MED, DEPT FORENS TOXICOL, SANTIAGO DE COMPOSTELA, SPAIN
关键词
D O I
10.1006/bbrc.1996.0791
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tetrahydroisoquinoline (TIQ), a presumed proneutrotoxin linked with Parkinson's disease (PD), was found to interact with some components of cigarette smoke to give N-(cyanomethyl)-TIQ (CMTIQ), N-(1'-cyanoethyl)-TIQ (CETIQ), N-(1'-cyanopropyl)-TIQ (CPTIQ), N-(1'-cyanobutyl)-TIQ (CBTIQ), and 1-cyano-TIQ (1CTIQ). The in vitro formation of these compounds under physiological conditions occurs rapidly and with a high yield. Significant differences in the recovery of the different compounds were obtained when the data obtained from Burley tobacco were compared to those obtained from Bright tobacco. Following chronic administration of TIQ and a solution of cigarette smoke to rats, the presence of some of these compounds was also detected in the brain. (C) 1996 Academic Press, Inc.
引用
收藏
页码:607 / 611
页数:5
相关论文
共 50 条
  • [1] Interactions between 1,2,3,4-tetrahydroisoquinoline and some components of tobacco smoke: Implication for Parkinson's disease
    SotoOtero, R
    Riguera, R
    MendezAlvarez, E
    SanchezSellero, I
    Lamas, MLR
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 : S53 - S53
  • [2] Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke
    MendezAlvarez, E
    SotoOtero, R
    SanchezSellero, I
    Lamas, MLR
    LIFE SCIENCES, 1997, 60 (19) : 1719 - 1727
  • [3] SYNTHESES OF 1-PHENETHL-1,2,3,4-TETRAHYDROISOQUINOLINE, 1-STYRYL-1,2,3,4-TETRAHYDROISOQUINOLINE, AND 1-ISOPENTYL-1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES
    ITO, K
    TANAKA, H
    ITO, T
    FURUKAWA, H
    YAKUGAKU ZASSHI, 1970, 90 (09): : 1144 - &
  • [4] Studies on the interaction between 1,2,3,4-tetrahydro-β-carboline and cigarette smoke:: a potential mechanism of neuroprotection for Parkinson's disease
    Soto-Otero, R
    Méndez-Alvarez, E
    Riguera, R
    Quiñoá, E
    Sánchez-Sellero, I
    Lamas, MLR
    BRAIN RESEARCH, 1998, 802 (1-2) : 155 - 162
  • [5] Reduction of rat brain levels of the endogenous dopaminergic proneurotoxins 1,2,3,4-tetrahydroisoquinoline and 1,2,3,4-tetrahydro-β-carboline by cigarette smoke
    Soto-Otero, R
    Méndez-Alvarez, E
    Sánchez-Sellero, I
    Cruz-Landeira, A
    Lamas, MLR
    NEUROSCIENCE LETTERS, 2001, 298 (03) : 187 - 190
  • [6] NMR SPECTRA OF 1-PHENETHYL-1,2,3,4-TETRAHYDROISOQUINOLINE AND 1-STYRYL-1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES
    ITO, K
    FURUKAWA, H
    TANAKA, H
    KATO, S
    YAKUGAKU ZASSHI, 1970, 90 (09): : 1169 - &
  • [7] Synthesis of 1,2,3,4-Tetrahydroisoquinoline Derivatives
    Feng, Zhiqiang
    Yang, Xiaoli
    Ye, Yuanfeng
    Hao, Lingyun
    Hu, Jingang
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2011, 31 (07) : 1087 - 1090
  • [8] SYNTHESIS AND PHARMACOLOGICAL CHARACTERIZATION OF 1-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINE, 4-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINE, AND 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE AS DOPAMINE RECEPTOR LIGANDS
    CHARIFSON, PS
    WYRICK, SD
    HOFFMAN, AJ
    SIMMONS, RMA
    BOWEN, JP
    MCDOUGALD, DL
    MAILMAN, RB
    JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (10) : 1941 - 1946
  • [9] The possibility of 1-methyl-1,2,3,4-tetrahydroisoquinoline, an amine present in human brain, as a medicine for Parkinson's disease
    Sano, T
    JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1999, 57 (02) : 136 - 140
  • [10] SYNTHESIS AND ACYLATION OF 1,2,3,4-TETRAHYDROISOQUINOLINE DERIVATIVES
    MIKHAILOVSKY, AG
    ALEXANDROV, BB
    VAKHRIN, MI
    KHIMIYA GETEROTSIKLICHESKIKH SOEDINENII, 1993, (06): : 780 - 783